Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 19/20 | 1.00 |
| ▸ | MCHR1 | Q99705 | 19/20 | 1.00 |
| ▸ | NPY5R | Q15761 | 17/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3938380 | 1.00 | ADRA2A (1.00) | ADRA2AMCHR1NPY5R | |
| SCHEMBL3941081 | 1.00 | ADRA2A (1.00) | ADRA2AMCHR1NPY5R | |
| Hydrochloric Acid SCHEMBL3939654 | 0.99 | MCHR1 (1.00) | ADRA2AMCHR1NPY5R | |
| Hydrochloric Acid SCHEMBL3939657 | 0.99 | MCHR1 (1.00) | ADRA2AMCHR1NPY5R | |
| SCHEMBL13796199 | 0.93 | MCHR1 (0.87) | ADRA2AMCHR1NPY5R | |
| Hydrochloric Acid SCHEMBL6612074 | 0.93 | ADRA2A (0.88) | ADRA2AMCHR1NPY5R | |
| SCHEMBL3938807 | 0.92 | MCHR1 (1.00) | ADRA2AMCHR1NPY5R | |
| SCHEMBL3937587 | 0.92 | MCHR1 (1.00) | ADRA2AMCHR1NPY5R | |
| SCHEMBL3937588 | 0.92 | MCHR1 (1.00) | ADRA2AMCHR1NPY5R | |
| SCHEMBL3947108 | 0.92 | MCHR1 (1.00) | ADRA2AMCHR1NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7544690-B2 | MCH receptor antagonists | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2009-06-09 | — | — | US | disclosed |
| US-20080242861-A1 | Synthesis of amino-protected cyclohexane-1,4-diyldimethanamine and its derivatives | TAIGEN BIOTECHNOLOGY (TW) | 2008-10-02 | — | — | US | disclosed |
| US-20070037836-A1 | Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1432693-A2 | MCH RECEPTOR ANTAGONISTS | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-06-30 | — | — | EP | disclosed |
| WO-2003028641-A2 | MCH RECEPTOR ANTAGONISTS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242861-A1 | Synthesis of amino-protected cyclohexane-1,4-diyldimethanamine and its derivatives | DDC, PNMT, DDT | ADRA2A 294/4885MCHR1 1276/4885NPY5R 976/4885 |
| US-20070037836-A1 | Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide | MCHR1, MCHR2, MC4R | ADRA2A 131/4885MCHR1 1/4885NPY5R 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.